How Early-stage VCs are Adjusting in a Bear Market
As part of a panel session, hosted by Stephen Hansen, at the Anglonordic Life Science conference on 5 May, Optimum’s clients explored the latest dynamics of syndicate building for early-stage VCs.
Tag Archive for: M Ventures
In Vivo’s 30 ‘Rising Leaders’ Announced
The 3rd annual listing of In Vivo’s ‘Rising Leaders’ has landed! Optimum is thrilled to see our brilliant clients from M Ventures, INKEF Capital, BioQube, Healthcap and Octarine recognised alongside other leading entrepreneurs and innovators in healthcare, from all across the globe. The 30 people spotlighted have been recognized for bringing something new to the […]
Merck KGaA, Darmstadt, Germany, Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the expansion of its strategic, corporate venture capital arm M Ventures Darmstadt, Germany, December 8, 2021: Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the expansion of its strategic, corporate venture capital arm M Ventures. The new investment of € […]
Accessing European Investment in a Post Covid-19 World
A video panel by Optimum in partnership with One Nucleus for ON Helix event held virtually in July 2020
INKEF Capital Appoints Roel Bulthuis as Managing Director to Co-Manage Eur 500m Fund
Venture fund focuses on supporting early stage healthcare and tech companies 27 November 2018, Amsterdam: INKEF Capital (INKEF), the Dutch venture capital fund focused on technology and healthcare, announces the appointment of Roel Bulthuis as Managing Director and Head of Healthcare Team. He will co-manage the INKEF fund alongside Robert Jan Galema, Head of Technology […]
